A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB)
Clinical trial NCT02797522 · TERMINATED
Trial details
- NCT number
- NCT02797522
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2016-11-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.